The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry
Year of publication: |
2011
|
---|---|
Authors: | Toole, Andrew A. |
Publisher: |
Mannheim : Zentrum für Europäische Wirtschaftsforschung (ZEW) |
Subject: | R&D | NIH | social return | biomedical | research lags | public science | new molecular entities |
Series: | ZEW Discussion Papers ; 11-063 |
---|---|
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Working Paper |
Language: | English |
Other identifiers: | 672465248 [GVK] hdl:10419/51353 [Handle] RePEc:zbw:zewdip:11063 [RePEc] |
Classification: | O31 - Innovation and Invention: Processes and Incentives ; O32 - Management of Technological Innovation and R&D ; L65 - Chemicals; Rubber; Drugs; Biotechnology ; H51 - Government Expenditures and Health |
Source: |
-
Toole, Andrew A., (2011)
-
Toole, Andrew A., (2012)
-
Toole, Andrew A., (2005)
- More ...
-
Biomedical Academic Entrepreneurship Through the SBIR Program
Toole, Andrew A., (2005)
-
Toole, Andrew A., (2005)
-
Business R&D and the Interplay of R&D Subsidies and Market Uncertainty
Czarnitzki, Dirk, (2006)
- More ...